| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Sandoz Canada Inc. · Status since Oct 2021 | 02299623 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Sandoz Canada Inc. · Status since Oct 2021 | 02299631 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Sandoz Canada Inc. · Status since Oct 2021 | 02299658 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Sandoz Canada Inc. · Status since Oct 2021 | 02330547 | Marketed | Sandoz Canada Inc. | Oct 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2.00 G)Sterimax Inc. · Status since Aug 2011 | 02362619 | Marketed | Sterimax Inc. | Aug 2011 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3.000 G)Sterimax Inc. · Status since Aug 2011 | 02362627 | Marketed | Sterimax Inc. | Aug 2011 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4.0 G)Sterimax Inc. · Status since Aug 2011 | 02362635 | Marketed | Sterimax Inc. | Aug 2011 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Sterimax Inc. · Status since Mar 2012 | 02377748 | Marketed | Sterimax Inc. | Mar 2012 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Auro Pharma Inc. · Status since Jun 2021 | 02402068 | Marketed | Auro Pharma Inc. | Jun 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Auro Pharma Inc. · Status since Jun 2021 | 02402076 | Marketed | Auro Pharma Inc. | Jun 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Auro Pharma Inc. · Status since Jun 2021 | 02402084 | Marketed | Auro Pharma Inc. | Jun 2021 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Sterimax Inc. · Status since Sep 2015 | 02439131 | Marketed | Sterimax Inc. | Sep 2015 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Sandoz Canada Inc. · Status since Apr 2022 | 02521539 | Marketed | Sandoz Canada Inc. | Apr 2022 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Eugia Pharma Inc. · Status since Nov 2024 | 02528673 | Marketed | Eugia Pharma Inc. | Nov 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Eugia Pharma Inc. · Status since Oct 2024 | 02528703 | Marketed | Eugia Pharma Inc. | Oct 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Eugia Pharma Inc. · Status since Oct 2024 | 02528711 | Marketed | Eugia Pharma Inc. | Oct 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Marcan Pharmaceuticals Inc. · Status since Oct 2023 | 02305623 | Approved | Marcan Pharmaceuticals Inc. | Oct 2023 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Marcan Pharmaceuticals Inc. · Status since Oct 2023 | 02305631 | Approved | Marcan Pharmaceuticals Inc. | Oct 2023 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Marcan Pharmaceuticals Inc. · Status since Oct 2023 | 02305658 | Approved | Marcan Pharmaceuticals Inc. | Oct 2023 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Apotex Inc. · Status since Aug 2018 | 02308444 | Dormant | Apotex Inc. | Aug 2018 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3.0 G)Apotex Inc. · Status since Aug 2017 | 02308452 | Dormant | Apotex Inc. | Aug 2017 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4.0 G)Apotex Inc. · Status since Aug 2017 | 02308460 | Dormant | Apotex Inc. | Aug 2017 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Auro Pharma Inc. · Status since Jun 2024 | 02549085 | Approved | Auro Pharma Inc. | Jun 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Auro Pharma Inc. · Status since Jun 2024 | 02549093 | Approved | Auro Pharma Inc. | Jun 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Eugia Pharma Inc. · Status since Aug 2024 | 02550393 | Approved | Eugia Pharma Inc. | Aug 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Eugia Pharma Inc. · Status since Aug 2024 | 02550407 | Approved | Eugia Pharma Inc. | Aug 2024 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Vpi Pharmaceuticals Inc · Status since Feb 2016 | 02452545 | Approved | Vpi Pharmaceuticals Inc | Feb 2016 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Vpi Pharmaceuticals Inc · Status since Feb 2016 | 02452553 | Approved | Vpi Pharmaceuticals Inc | Feb 2016 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Vpi Pharmaceuticals Inc · Status since Feb 2016 | 02452561 | Approved | Vpi Pharmaceuticals Inc | Feb 2016 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Vpi Pharmaceuticals Inc · Status since Feb 2016 | 02452588 | Approved | Vpi Pharmaceuticals Inc | Feb 2016 |
| VPI-PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Vpi Pharmaceuticals Inc · Status since Feb 2016 | 02452596 | Approved | Vpi Pharmaceuticals Inc | Feb 2016 |
| JAMP-PIP/TAZ (4 G)JAMP Pharma Corporation · Status since Sep 2022 | 02420430 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION (2 G)Teva Canada Limited · Status since Jul 2025 | 02370158 | Cancelled Post Market | Teva Canada Limited | Jul 2025 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION (3 G)Teva Canada Limited · Status since Nov 2019 | 02370166 | Cancelled Post Market | Teva Canada Limited | Nov 2019 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION (4 G)Teva Canada Limited · Status since Feb 2018 | 02370174 | Cancelled Post Market | Teva Canada Limited | Feb 2018 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Mylan Pharmaceuticals Ulc · Status since Jul 2016 | 02391511 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2016 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Mylan Pharmaceuticals Ulc · Status since Jul 2016 | 02391538 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2016 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Mylan Pharmaceuticals Ulc · Status since Jul 2016 | 02391546 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2016 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (2 G)Hikma Canada Limited · Status since Jan 2023 | 02401312 | Cancelled Post Market | Hikma Canada Limited | Jan 2023 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (3 G)Hikma Canada Limited · Status since Sep 2022 | 02401320 | Cancelled Post Market | Hikma Canada Limited | Sep 2022 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (4 G)Hikma Canada Limited · Status since Jun 2022 | 02401339 | Cancelled Post Market | Hikma Canada Limited | Jun 2022 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (12 G)Fresenius Kabi Canada Ltd · Status since Aug 2024 | 02465825 | Cancelled Pre Market | Fresenius Kabi Canada Ltd | Aug 2024 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION (36 G)Fresenius Kabi Canada Ltd · Status since Jun 2025 | 02465833 | Cancelled Post Market | Fresenius Kabi Canada Ltd | Jun 2025 |
| PIPERACILLIN FOR INJECTION (2 G)Hospira Healthcare Corporation · Status since Jul 2017 | 02246640 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2017 |
| PIPERACILLIN FOR INJECTION (3 G)Hospira Healthcare Corporation · Status since Apr 2019 | 02246641 | Cancelled Post Market | Hospira Healthcare Corporation | Apr 2019 |
| PIPERACILLIN FOR INJECTION (4 G)Hospira Healthcare Corporation · Status since Jul 2017 | 02246642 | Cancelled Post Market | Hospira Healthcare Corporation | Jul 2017 |
| PIPERACILLIN FOR INJECTION (2 G)Fresenius Kabi Canada Ltd · Status since Oct 2021 | 02248939 | Cancelled Post Market | Fresenius Kabi Canada Ltd | Oct 2021 |
| PIPERACILLIN FOR INJECTION (3 G)Fresenius Kabi Canada Ltd · Status since Oct 2021 | 02248940 | Cancelled Post Market | Fresenius Kabi Canada Ltd | Oct 2021 |
| PIPERACILLIN FOR INJECTION (4 G)Fresenius Kabi Canada Ltd · Status since Oct 2021 | 02248941 | Cancelled Post Market | Fresenius Kabi Canada Ltd | Oct 2021 |
| PIPERACILLIN/TAZOBACTAM FOR INJECTION (2 G)Pharma Strides Canada Corporation · Status since Jul 2012 | 02305593 | Cancelled Post Market | Pharma Strides Canada Corporation | Jul 2012 |
| PIPERACILLIN/TAZOBACTAM FOR INJECTION (3 G)Pharma Strides Canada Corporation · Status since Jul 2012 | 02305607 | Cancelled Post Market | Pharma Strides Canada Corporation | Jul 2012 |
| PIPERACILLIN/TAZOBACTAM FOR INJECTION (4 G)Pharma Strides Canada Corporation · Status since Jul 2012 | 02305615 | Cancelled Post Market | Pharma Strides Canada Corporation | Jul 2012 |
| PIPRACIL INJ 2GM/VIAL (2 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 00564974 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |
| PIPRACIL INJ 3GM/VIAL (3 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 00564982 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |
| PIPRACIL INJ 4GM/VIAL (4 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 00564990 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |
| PIPRACIL PHARMACY BULK 40GM/VIAL (40 G)Cyanamid Canada Inc. · Status since Aug 2000 | 00857548 | Cancelled Post Market | Cyanamid Canada Inc. | Aug 2000 |
| PIPRACIL PHARMACY BULK VIAL-PWS IV 40G/VIAL (40 G)Wyeth-Ayerst Canada Inc. · Status since Oct 2002 | 02173697 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Oct 2002 |
| PIPRACIL-PWS IM IV 4G/VIAL (4 G)Wyeth Canada · Status since Jun 2004 | 02173441 | Cancelled Post Market | Wyeth Canada | Jun 2004 |
| PIPRACIL-PWS IV IM 2G/VIAL (2 G)Wyeth Canada · Status since Jun 2004 | 02173425 | Cancelled Post Market | Wyeth Canada | Jun 2004 |
| PIPRACIL-PWS IV IM 3G/VIAL (3 G)Wyeth Canada · Status since Jun 2004 | 02173433 | Cancelled Post Market | Wyeth Canada | Jun 2004 |
| TAZOCIN (3 G)Pfizer Canada Ulc · Status since Feb 2015 | 02170795 | Cancelled Post Market | Pfizer Canada Ulc | Feb 2015 |
| TAZOCIN (4 G)Pfizer Canada Ulc · Status since Apr 2015 | 02170809 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2015 |
| TAZOCIN (2 G)Pfizer Canada Ulc · Status since Apr 2015 | 02170817 | Cancelled Post Market | Pfizer Canada Ulc | Apr 2015 |
| TAZOCIN PWS IV 2G PIPERACILLIN-.25G TAZOBAC. (2 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 02083590 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |
| TAZOCIN PWS IV 3G PIPERACILLIN-.375G TAZOBAC (3 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 02083604 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |
| TAZOCIN PWS IV 4G PIPERACILLIN-.5G TAZOBAC. (4 G)Lederle Cyanamid Canada Inc. · Status since Aug 2000 | 02083612 | Cancelled Post Market | Lederle Cyanamid Canada Inc. | Aug 2000 |